Radiomics.bio
    Insight-based
    decision making

    Diseases and
    therapeutic areas

    Discover
    where we are active

    Industry
    and Pharma

    Discover
    our services

    Healthcare
    professionals

    Discover
    our products

    Scientific
    researchers

    Discover
    our expertise

    About Radiomics.bio

    Radiomics.bio is an imaging research organisation built upon the unparallel experience of its founders, pioneers of the radiomics science.
     
    Radiomics.bio focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas. Through our proprietary advanced image analysis technology, we aim to unravel the gold mine of hidden data information embedded in standard medical images.
     
    Radiomics enables insight-based decision making to optimise clinical trials and drug development studies and to provide clinicians with a patient-centered approach based on personalized medicine. With these objectives, Radiomics.bio’s R&D team is continuously working on new solutions, in collaboration with multiple national and international partners.
    Read more

    We can help you

    optimise

    Optimise

    Your clinical trials (in terms of costs and time)

    detect

    Detect

    The subtlest signals of drugs efficacy and safety risk
    facilitate

    Facilitate

    Your crucial
    go / no-go
    decisions
    identify

    Identify

    Patients likely to respond to your treatment
    strenghten

    Strengthen

    Your points
    in pay for outcome scenarios

    Why Radiomics.bio

    Experience

    Our scientists and clinicians are the ones who invented radiomics and have unparalleled experience and international recognition in this AI field.

    Outreach

    Radiomics.bio has clients and partners in the EU, the US, Africa and Australia. Radiomics has a permanent presence in North America with a fully owned affiliate in Toronto.

    IP Portfolio

    Radiomics.bio's comprehensive IP portfolio includes both granted and pending international (EU/US) patents.

    People

    Radiomics.bio's team is composed of a multicultural and multidisciplinary set of people, specialized in a broad range of domains always enthusiastic in addressing clients and partner's needs. 

    Publications

    Radiomics.bio has numerous publications in high impact journals such as Nature Reviews, Clinical Oncology, Annals of Oncology and many more. 

    Latest news

    news
    • February 29th, 2024

    From Images to Impact: Radiomics' Solutions to Challenges in Immunotherapy

    Up to 30% of patients may experience hyper progression following immunotherapy. Identifying patients who will actually benefit from immunotherapy is intrinsic to achieving optimal outcomes. Radiomics can offer a solution to this problem by analysing the phenotypical changes in lesions and organs that may occur following the initiation of a treatment.

    Read more
    press
    • September 5th, 2023

    Pilot project at the Jewish General Hospital aims to accelerate access to new and highly effective treatments for cancer patients

    Pilot project at the Jewish General Hospital aims to accelerate access to new and highly effective treatments for cancer patients

    Read more
    press
    • April 7th, 2023

    Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy

    DeuterOncology joins forces with Radiomics to develop a clinical tool to predict patient response to treatment.

    Read more
    Read our latest news
    radiomics logo
    ISO 13485 Certification
    Go to
    diseases and therapeutic areas
    industry & pharma
    healthcare professionals
    scientific researchers & academia
    Contact
    LégiaPark
    Boulevard Patience et Beaujonc 3
    4000 Liège
    Belgium
    BE.0662.719.440
    [email protected]
    Design: Erinas